Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects ...

You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05/2001. An increasingly popular option among retail and institutional investors ...

If you’re looking for biotech stocks to buy, the iShares Biotechnology ETF (NASDAQ:IBB) is an excellent place to start. It tracks the performance of the ICE Biotechnology Index, a collection of ...

Any pullbacks in IBB should be bought for long-term equity appreciation. IBB is the iShares Biotechnology ETF. IBB tracks the investment performance of an index composed of U.S.-listed equities in ...

The healthcare sector is poised for strong growth, driven by aging populations, technological advancements, and increased ...

The infrastructure industry is thriving, driven by rising investments in advanced capabilities, increasing demand, and ...

BlackRock is the world's largest asset manager, with $11.5 trillion in client money under its supervision. Around $3.3 ...

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on ...

Legacy Private Trust Co. lowered its stake in iShares S&P Mid-Cap 400 Growth ETF (NYSEARCA:IJK – Free Report) by 2.1% during ...

iShares Biotechnology ETF earns an Average Process Pillar rating. Morningstar's algorithmically assigned Passive Process ratings are first formulated by comparing the historical efficacy of ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...